2020 has been a tough year for all of us. The global epidemic made us aware of our vulnerability both in our personal health as our businesses. But has also shown our flexibility to adapt quickly to these changes.
Some sectors are hit very hard while others benefit, you also must have questions on how to adapt to this new reality. Maybe our market studies can help you do so!
Until the end of 2020 we offer discounts on single and bundle report purchases.
Single report purchase
For most reports, the "Year-End" discount is shown in the adjusted prices of the reports and are automatically calculated when you order. If discounts are not visible please use the "Request Discount" option on the specific report page, this indicates that discounts may vary during the discount period.
If you have an interest in multiple reports, we are able to calculate a bundle discount on top of the individual report discounts. To request this bundle discount, you can create your wish-list using the button on the report pages. If you have added all reports to your wish-list please forward the wish-list to us with the special button and we will send you our quotation.
If you have any questions or inquiries, do not hesitate to contact us!
In this research deliverable, Frost & Sullivan’s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new trials. This research service will help participants plan their production pipeline and be well prepared to tackle the dynamic market situation and the post-COVID-19 impact. This short report covers the Global Contract Research Organization Market (CRO) insights, with forecast for the total CRO market, including drug discovery and preclinical markets, with 2019 as the base year and 2020–2024 as the forecast period. Market revenue is measured in US dollars. It presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides global, post-pandemic revenue forecasts for CROs. Further, qualitative information will be provided on support services, such as central laboratory services, bioanalytics, and data management. The report identifies strong CRO opportunities, with the evolving digitized ecosystem of the clinical trials due to COVID-19. The two key market trends identified are increased adoption of hybrid clinical trials and remote patient monitoring.
Pre-/post-COVID-19 impact and growth trajectory of the CRO market